Prostate cancer affects 1 in 4 Black men, compared to 1 in 8 men of other ethnicities. Our analysis has revealed that not enough is being done to address this, leading us to take both an awareness-raising and a research initiative in 2021. 


At Prostate Cancer Research (PCR) we are committed to funding the gaps we see in the research ecosystem. For this grant call, PCR has decided to focus on addressing racial disparities in prostate cancer. Our analysis has revealed that not enough is being done to address this stark disparity. 

 We are accepting proposals for innovative, ambitious research projects that address key challenges pertaining to the health inequalities experienced by the Black community that are relevant to prostate cancer.  

PCR seeks to maximize the impact of every pound it invests in research. Several smaller grants may be considered to deliver more impact for prostate cancer patients than a single large grant. Applicants should consider their budgets carefully and minimize discretionary expenditure that does not deliver value for money. 


Areas of Research Interest

This call aims to address some of the key challenges contributing to the health inequalities experienced by the Black community and we welcome proposals from the fields of biomedical and social sciences. While we are interested in the areas of research below, we will consider any research avenue relevant to men with advanced prostate cancer: 

  1. The lack of diversity in clinical research studies, the barriers that exist to participation in research by members of the Black community and how can these be overcome. 
  2. Research looking at the biological factors that affect prostate cancer prognosis for Black men, including further investigation into what genomic and epigenetic alternations are in order to develop target treatment options or whether Black and White men fare equally on prostate cancer therapies. 
  3. If and how genetic screening can be used to reduce the number of Black men being diagnosed with advanced and/or aggressive prostate cancer. 
  4. The fears, perceptions and psychosocial impact of prostate cancer in the Black community and how to make public health messaging more appropriate, effective and supportive to the needs of this community.   
  5. If and how NHS cancer service experiences differ between ethnicities, and if a disparity in care is found, how it can be resolved. 


Career Stage 

This award is open to researchers with a PhD (or equivalent higher research degree) and a minimum three (3) years post-PhD experience affiliated to a recognized educational or healthcare institution. However, if you have less than three (3) years of independent research experience, you may still apply under the mentorship of a senior researcher. We encourage involvement from community groups and patients, including as co-investigators and/or collaborators. 



The lead applicant must be based at a university or research institution or hospital in the UK or US. National or international collaborations will be considered as long as the award can be administered through a lead host institution based in either country. 


Research Strategy 

All proposals must align with our Research Strategy and should be innovative, solution-oriented and seek to develop recommendations. 

 The three main criteria used to select successful projects will be: 

  • Relevance to people affected by prostate cancer 
  • Scientific excellence and innovation 
  • Collaboration with other scientists 

Duration and Level of Funding

Proposals can be up to $400,000 and between 1-3 years. We particularly want to support early career researchers, and researchers who prioritize collaboration. 



Please download and complete the EOI form below and return it, as a word document only, to [email protected]The submission deadline is 23:59 on Sunday 17th October 2021. 

If you have not received an acknowledgement of your application within four days of your submitting it, please contact us immediately to confirm we have received it. 


If you have any other queries, please contact the research team at [email protected] 


Press enter or esc to cancel